Progress of research on clarithromycin for treatment of multiple myeloma / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 246-249, 2015.
Artículo
en Chino
| WPRIM
| ID: wpr-259606
ABSTRACT
Clarithromycin is a 14-membered ring macrolide antibiotics that is widely used in the treatment of infectious disease. Several clinical investigations showed that clarithromycin was highly efficient for multiple myeloma in improving response rate and survival when used in combination with the conventional chemotherapy since 1997. This finding highlights the importance of clarithromycin on the treatment of multiple myeloma. It offers a new regimen for the relapsed/refractory multiple myeloma patients, and provids a new thought for the treatment of multiple myeloma. However, its related mechanism is still unclear, and more investigations are needed. This review summerizes the recent research progress of clarithromycin for treatment of multiple myeloma and its potential mechanisms.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Talidomida
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Claritromicina
/
Mieloma Múltiple
Límite:
Humanos
Idioma:
Chino
Revista:
Journal of Experimental Hematology
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS